Recursion Pharmaceuticals Inc Clas (RXRX)

Income Before Tax

-$523.47M

TTM · Period ending: · USD

RXRX logo

RXRX Income Before Tax

Latest reported-$523.47M
RXRX TTM Pre-Tax Income (-$87.01M → -$523.47M)
High-resolution chart · PNG

RXRX income before tax history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Recursion Pharmaceuticals Inc Clas Income Before Tax — Trailing twelve months (TTM) (USD)
Period endingIncome Before Tax (USD)
-523,466,000
-564,357,000
-644,894,000
-715,691,000
-649,116,000
-575,282,000
-464,789,000
-382,948,000
-380,290,000
-358,954,000
-332,129,000
-292,563,000
-259,991,000
-248,824,000
-239,476,000
-246,917,000
-233,900,000
-211,741,000
-186,479,000
-147,312,000
-123,757,000
-99,299,000
-87,006,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.